 |
 |
Home | Contact Us
|
|
|
|
|
|
|
||
Home | Contact Us |
|
|
||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
The decline in incidence of kidney failure represents an encouraging trend in this serious complication of diabetes. To continue improving this trend, persons with diabetes or high blood pressure should talk with their doctor and get checked for kidney disease.
| PRESS CONTACT: CDC National Center for Chronic Disease Prevention and Health Promotion Office of Communication (770) 488-5131 |
Diabetes is the leading cause of end-stage renal disease (ESRD) (i.e., kidney failure requiring dialysis or transplantation) in the United States, accounting for 44 percent of new cases of treated ESRD in 2002. Our findings indicate that, although the number of new cases of ESRD-DM continues to increase, the incidence of ESRD-DM among persons with diabetes is no longer increasing among persons aged 65鈥?4 years, men, blacks, and Hispanics, and it is declining among those younger than 65 years, women, and whites. Continued interventions to reduce the prevalence of kidney disease risk factors, such as blood sugar and blood pressure control, and improve the level of diabetes care are needed to sustain and improve these trends.
An effective worldwide measles/rubella laboratory network has been developed which supports the control and elimination of measles and rubella.
| PRESS CONTACT: Dave Daigle CDC, National Center for Infectious Diseases (404) 639-1143 |
Measles and rubella control and elimination programs depend on effective global surveillance. Serological testing and genetic characterization performed within the Measles and Rubella Laboratory Network (LabNet) improves the accuracy of case identification and confirmation, thus improving the quality of disease surveillance. About 190 laboratories worldwide can now perform IgM testing on sera from suspected cases, and virological (genotyping) information is now available on viruses from every WHO region. Genotype information can help to document viral transmission pathways, aid in case classification, and help to document the elimination of endemic disease. Both surveillance activities and vaccination programs must be continued in countries where measles or rubella have been eliminated, since there is still a threat of disease importation from endemic areas.
| PRESS CONTACT: CDC Division of Media Relations (404) 639-3286 |
No Summary Available.
| PRESS CONTACT: CDC Division of Media Relations (404) 639-3286 |
No Summary Available.
|
|
Media Home | Accessibility
| Privacy Policy | Contact Us This page last reviewed November 3, 2005 Centers for Disease Control and Prevention |
